Issue Date | Title | Author(s) |
2021-03-01 | A methods review of posttrial follow-up studies of cardiovascular prevention finds potential biases in estimating legacy effects. | Zhu, L; Bell, KJL; Nayak, A; Hayen, A |
2014-01-01 | Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: Secondary analysis of observational study data | Bell, KJL; Beller, E; Sundström, J; McGeechan, K; Hayen, A; Irwig, L; Neal, B; Glasziou, P |
2017-01-17 | Change in bone mineral density is an indicator of treatment-related antifracture effect | Bell, KJL; Hayen, A; Glasziou, P; Irwig, L; Bauer, DC |
2022-05-10 | Clinician views and experiences of non-invasive prenatal genetic screening tests in Australia. | McKinn, S; Javid, N; Newson, AJ; Freeman, L; Bonner, C; Shand, AW; Nassar, N; Bell, KJL |
2014-02-01 | Criteria for monitoring tests were described: Validity, responsiveness, detectability of long-term change, and practicality | Bell, KJL; Glasziou, PP; Hayen, A; Irwig, L |
2017-03 | EARLY CRT MONITORING USING TIME-DOMAIN OPTICAL COHERENCE TOMOGRAPHY DOES NOT ADD TO VISUAL ACUITY FOR PREDICTING VISUAL LOSS IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL RANIBIZUMAB: A Secondary Analysis of Trial Data. | Bell, KJL; Hayen, A; Glasziou, P; Mitchell, AS; Farris, M; Wright, J; Duerr, H-P; Mitchell, P; Irwig, L |
2019-01-01 | Erratum: Prognostic impact of systolic blood pressure variability in people with diabetes (PLoS ONE (2019) 13:4(e0194084)DOI:10.1371/journal.pone.0194084) | Bell, KJL; Azizi, L; Nilsson, PM; Hayen, A; Irwig, L; Östgren, CJ; Sundström, J |
2019-10-01 | Estimated legacy effects from simulated post-trial data were less biased than from combined trial/post-trial data | Zhu, L; Bell, KJL; Hayen, A |
2022-06-13 | Learning from the pandemic: mortality trends and seasonality of deaths in Australia in 2020. | Gregory, G; Zhu, L; Hayen, A; Bell, KJL |
2020-03-05 | Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study. | Zhu, L; Hayen, A; Bell, KJL |
2020-11 | Mammography screening for breast cancer-the UK Age trial. | Bell, KJL; Irwig, L; Nickel, B; Hersch, J; Hayen, A; Barratt, A |
2023-08 | Methods to address selection bias in post-trial studies of legacy effects were evaluated. | Zhu, L; Bell, KJL; Hayen, A |
2011-01-29 | Monitoring adherence to drug treatment by using change in cholesterol concentration: Secondary analysis of trial data | Bell, KJL; Kirby, A; Hayen, A; Irwig, L; Glasziou, P |
2011-12-10 | Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma | Turner, RM; Bell, KJL; Morton, RL; Hayen, A; Francken, AB; Howard, K; Armstrong, B; Thompson, JF; Irwig, L |
2012-01-01 | The potential value of monitoring bone turnover markers among women on alendronate | Bell, KJL; Hayen, A; Irwig, L; Hochberg, MC; Ensrud, KE; Cummings, SR; Bauer, DC |
2018-04-01 | Prognostic impact of systolic blood pressure variability in people with diabetes | Bell, KJL; Azizi, L; Nilsson, PM; Hayen, A; Irwig, L; Östgren, CJ; Sundröm, J |
2023-05 | Regular high-frequency whole blood donation and risk of cardiovascular disease in middle-aged and older blood donors in Australia. | Karki, S; Bell, KJL; Hayen, A; Liu, B; Cust, AE; Olynyk, JK; Irving, DO |
2013-05-04 | When to remeasure cardiovascular risk in untreated people at low and intermediate risk: Observational study | Bell, KJL; Hayen, A; Irwig, L; Takahashi, O; Ohde, S; Glasziou, P |